• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征患者的二肽基肽酶4活性会升高吗?

Is DPP4 activity increased in PCOS?

作者信息

Braga Letícia Dinis da C, Godoy-Matos Amelio F, Siciliano Priscila de Oliveira, Corrêa José Otávio do Amaral, Carvalho Denise Pires

机构信息

Metabolism unit, Instituto Estadual de Diabetes e Endocrinologia (IEDE), Rio de Janeiro, RJ, Brazil.

Metabolism unit, Instituto Estadual de Diabetes e Endocrinologia (IEDE), Rio de Janeiro, RJ, Brazil.

出版信息

Diabetes Metab Syndr. 2018 Sep;12(5):673-675. doi: 10.1016/j.dsx.2018.04.032. Epub 2018 Apr 14.

DOI:10.1016/j.dsx.2018.04.032
PMID:29680519
Abstract

AIMS

Dipeptidyl peptidase-4 (DPP4) is an adipokine with greater expression in visceral fat and related with insulin resistance (IR). Polycystic ovary syndrome (PCOS) is also associated with IR. Our study aims to evaluate DPP4 activity in PCOS.

MATERIALS AND METHODS

Thirty PCOS patients were compared to 28 healthy women. Body composition by dual X-ray absorptiometry (DXA), plasma activity of DPP4 and biochemical variables were performed. All participants underwent an oral glucose tolerance test for insulin and glucose analysis.

RESULTS

DPP4 activity was similar in both groups (PCOS 5823 ± 926 vs Control 5501.8 ± 975; p = 0.20). PCOS patients were more IR with lower levels of SHBG (32 vs 47, p = 0.02) and Matsuda index (15.6 vs 20.4, p = 0.03) and higher HOMA-IR (2.8 vs 1.7, p < 0.01), in addition to increased levels of testosterone (55 vs 25, p < 0.01). DPP4 was correlated to HbA1c (r = 0.279, p = 0.03), HDL-c (r = -0.28, p = 0.03) and SHBG (r = -0.256, p = 0.05).

CONCLUSIONS

Although PCOS was well characterized as IR and hyperandrogenic, DPP4 was not different in this group. However, a relationship between DPP4 and markers of IR were found. More studies are warranted.

摘要

目的

二肽基肽酶-4(DPP4)是一种脂肪因子,在内脏脂肪中表达较高,与胰岛素抵抗(IR)相关。多囊卵巢综合征(PCOS)也与IR有关。我们的研究旨在评估PCOS患者的DPP4活性。

材料与方法

将30例PCOS患者与28名健康女性进行比较。采用双能X线吸收法(DXA)测量身体成分,检测DPP4的血浆活性及生化指标。所有参与者均接受口服葡萄糖耐量试验以分析胰岛素和葡萄糖水平。

结果

两组的DPP4活性相似(PCOS组为5823±926,对照组为5501.8±975;p = 0.20)。PCOS患者存在更多IR,其性激素结合球蛋白(SHBG)水平较低(32 vs 47,p = 0.02),松田指数较低(15.6 vs 20.4,p = 0.03),稳态模型评估的胰岛素抵抗指数(HOMA-IR)较高(2.8 vs 1.7,p < 0.01),此外睾酮水平升高(55 vs 25,p < 0.01)。DPP4与糖化血红蛋白(HbA1c)(r = 0.279,p = 0.03)、高密度脂蛋白胆固醇(HDL-c)(r = -0.28,p = 0.03)和SHBG(r = -0.256,p = 0.05)相关。

结论

尽管PCOS具有IR和高雄激素血症的典型特征,但该组患者的DPP4并无差异。然而,发现DPP4与IR标志物之间存在关联。有必要开展更多研究。

相似文献

1
Is DPP4 activity increased in PCOS?多囊卵巢综合征患者的二肽基肽酶4活性会升高吗?
Diabetes Metab Syndr. 2018 Sep;12(5):673-675. doi: 10.1016/j.dsx.2018.04.032. Epub 2018 Apr 14.
2
Dipeptidyl peptidase 4 serum activity and concentration are increased in women with polycystic ovary syndrome.多囊卵巢综合征妇女血清二肽基肽酶 4 活性和浓度增加。
Clin Endocrinol (Oxf). 2017 Dec;87(6):741-747. doi: 10.1111/cen.13444. Epub 2017 Sep 13.
3
DPP4 activity is related to body weight and central fat in postmenopausal women.二肽基肽酶4(DPP4)活性与绝经后女性的体重及腹部脂肪有关。
Diabetes Metab Syndr. 2019 Sep-Oct;13(5):3031-3034. doi: 10.1016/j.dsx.2018.07.008. Epub 2018 Jul 17.
4
DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY.DPP4 抑制剂西格列汀作为二甲双胍不耐受的肥胖多囊卵巢综合征女性的潜在治疗选择:一项先导随机研究。
Endocr Pract. 2018 Jan;24(1):69-77. doi: 10.4158/EP-2017-0027. Epub 2017 Nov 16.
5
Preptin in women with polycystic ovary syndrome.多囊卵巢综合征女性中的前动力蛋白原
Gynecol Endocrinol. 2018 Jun;34(6):470-475. doi: 10.1080/09513590.2017.1409715. Epub 2018 Jan 27.
6
Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.通过全身双能X线吸收扫描和人体测量学方法测量局部脂肪量以预测多囊卵巢综合征女性及对照者胰岛素抵抗的比较。
Acta Obstet Gynecol Scand. 2016 Nov;95(11):1235-1243. doi: 10.1111/aogs.12964.
7
Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia.多囊卵巢综合征女性的血清瘦素水平:胰岛素抵抗/高胰岛素血症的作用
J Clin Endocrinol Metab. 1997 Jun;82(6):1692-6. doi: 10.1210/jcem.82.6.4028.
8
Plasma DPP4 Activities Are Associated With Osteoporosis in Postmenopausal Women With Normal Glucose Tolerance.血浆 DPP4 活性与葡萄糖耐量正常的绝经后妇女骨质疏松症有关。
J Clin Endocrinol Metab. 2015 Oct;100(10):3862-70. doi: 10.1210/jc.2015-2233. Epub 2015 Aug 10.
9
Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.运动对超重和肥胖伴多囊卵巢综合征与不伴多囊卵巢综合征妇女胰岛素抵抗和身体成分的影响。
J Clin Endocrinol Metab. 2011 Jan;96(1):E48-56. doi: 10.1210/jc.2010-0828. Epub 2010 Oct 6.
10
The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome.多囊卵巢综合征患者血清雄激素、胰岛素抵抗与脂肪分布的关联
Eur J Obstet Gynecol Reprod Biol. 2006 May 1;126(1):81-6. doi: 10.1016/j.ejogrb.2005.11.012. Epub 2005 Dec 7.

引用本文的文献

1
Decreased Serum Levels of the Insulin Resistance-Related microRNA miR-320a in Patients with Polycystic Ovary Syndrome.多囊卵巢综合征患者血清中与胰岛素抵抗相关的微小RNA miR-320a水平降低。
Curr Issues Mol Biol. 2024 Apr 15;46(4):3379-3393. doi: 10.3390/cimb46040212.
2
Quantitative Proteomics Reveals That a Prognostic Signature of the Endometrium of the Polycystic Ovary Syndrome Women Based on Ferroptosis Proteins.定量蛋白质组学揭示了基于铁死亡蛋白的多囊卵巢综合征女性子宫内膜的预后特征。
Front Endocrinol (Lausanne). 2022 Jul 14;13:871945. doi: 10.3389/fendo.2022.871945. eCollection 2022.
3
Serum dipeptidyl peptidase-4 activity and progranulin level in polycystic ovary syndrome patients.
多囊卵巢综合征患者的血清二肽基肽酶-4活性及前颗粒蛋白水平
Caspian J Intern Med. 2022 Winter;13(1):70-75. doi: 10.22088/cjim.13.1.70.
4
Knockdown of DPP4 promotes the proliferation and the activation of the CREB/aromatase pathway in ovarian granulosa cells.敲低 DPP4 可促进卵巢颗粒细胞中 CREB/芳香酶途径的增殖和激活。
Mol Med Rep. 2022 Feb;25(2). doi: 10.3892/mmr.2022.12589. Epub 2022 Jan 11.
5
Imaging-Based Body Fat Distribution in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.基于影像学的多囊卵巢综合征患者体脂分布:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2021 Sep 9;12:697223. doi: 10.3389/fendo.2021.697223. eCollection 2021.
6
The Potential Effect of on Polycystic Ovary Syndrome Based on Network Pharmacology and Molecular Docking.基于网络药理学和分子对接研究 对多囊卵巢综合征的潜在作用
Evid Based Complement Alternat Med. 2021 Jul 8;2021:5577610. doi: 10.1155/2021/5577610. eCollection 2021.
7
DPP4 Activities Are Associated with Osteopenia/Osteoporosis and Fracture Risk in Newly Diagnosed Type 2 Diabetes.二肽基肽酶4活性与新诊断2型糖尿病患者的骨质减少/骨质疏松及骨折风险相关。
Int J Endocrinol. 2020 Nov 27;2020:8874272. doi: 10.1155/2020/8874272. eCollection 2020.